Table 5.
Comparison of anthropometric data and questionnaires scores between week 12 and week 0 data (expressed as ∆)
| ALL | VLCKD | HBD | p-value | |
|---|---|---|---|---|
| 41 (100) | 26 (63.4) | 15 (36.6) | ||
| Weight (kg) | − 7.5 ± 5.7 | − 9.1 ± 6.4 | − 4.9 ± 2.7 | 0.020 |
| BMI (kg/m2) | − 2.7 ± 2.0 | − 3.3 ± 2.2 | − 1.8 ± 1.0 | 0.016 |
| WC (cm) | − 7.5 ± 7.0 | − 9.2 ± 7.4 | − 4.6 ± 5.2 | 0.041 |
| HC (cm) | − 7.4 ± 5.5 | − 8.8 ± 5.9 | − 4.9 ± 3.9 | 0.029 |
| Systolic BP (mmHg) | − 8.5 ± 16.2 | − 11.3 ± 16.6* p = 0.005 | − 5.2 ± 15.0 | 0.259 |
| Diastolic BP (mmHg) | − 4.5 ± 10.2 | − 5.58 ± 9.57* p = 0.031 | − 4.2 ± 10.3 | 0.673 |
| Heart Frequency | 1.3 ± 10 | 2.48 ± 10.1 | − 0.6 ± 9.76 | 0.352 |
| MMDs (n/month) | − 5.7 ± 5.2 | − 7.2 ± 5.4 | − 3.1 ± 3.6 | 0.014 |
| Migraine attack duration (hours) | − 13.5 ± 20.0 | − 13.8 ± 19.3 | − 12.9 ± 22.2 | 0.911 |
| MIDAS | − 25.9 ± 38.4 | − 22.0 ± 43.3 | − 32.5 ± 28.3 | 0.426 |
| HIT-6 | − 6.0 ± 6.9 | − 6.3 ± 6.7 | − 5.4 ± 7.5 | 0.697 |
| VAS | − 1.9 ± 1.9 | − 1.8 ± 1.6 | − 2.1 ± 2.3 | 0.632 |
| SF-36 PF | 12.3 ± 11.3 | 12.83 ± 10.6 ** p < 0.001 |
11.42 ± 12.77 * p = 0.005 |
0.722 |
| SF-36 RP | 23.6 ± 46.8 | 18.48 ± 47.80 |
32.14 ± 45.39 * p = 0.020 |
0.396 |
| SF-36 BP | 12.0 ± 15.5 | 12.30 ± 13.58 ** p < 0.001 |
11.57 ± 18.82 *p = 0.039 |
0.891 |
| SF-36 GH | 6.8 ± 12.5 | 6.65 ± 14.81 * p = 0.043 |
7.07 ± 7.95 * p = 0.005 |
0.923 |
| SF-36 VT | 13.9 ± 16.1 | 16.52 ± 18.05 ** p < 0.001 |
9.64 ± 11.84 *p = 0.009 |
0.214 |
| SF-36 SF | 14.7 ± 23.7 | 13.95 ± 24.76 *p = 0.013 |
16.0 ± 22.66 *p = 0.02 |
0.803 |
| SF-36 RE | 23.5 ± 55.5 | 20.26 ± 63.43 |
28.71 ± 41.07 *p = 0.021 |
0.660 |
| SF-36 MH | 6.8 ± 12.6 | 8.0 ± 14.16 **p = 0.0013 | 4.86 ± 9.57 | 0.469 |
| SF-36 total | 1.7 ± 6.3 | 0.95 ± 6.50 | 2.71 ± 6.05 | 0.426 |
BMI, body mass index; WC, waist circumference; HC, hip circumference; BP, blood pressure, physical functioning (PF), role—physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role—emotional (RE), and mental health (MH). We have highlighted with * the significant differences between baseline and week 12 in each group
All values are presented as mean ± standard deviation, or percentage. Differences were considered statistically significant when p was < 0.05. Significant p values are highlighted in bold